Inmune Bio's total assets for Q2 2025 were $37.68M, a decrease of -0.31% from the previous quarter. INMB total liabilities were $8.82M for the fiscal quarter, a 8.48% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.